GGrantIndex
Sort

261,768 grants matching “gene therapy”

ADalimumab Vs. conventional ImmunoSupprEssion for uveitis(ADVISE) Trial

$1,915,534
Janet T. Holbrook · Johns Hopkins University · UG1 · FY2019 · EY

Gene Therapy for Hemophilia

$1,915,518
Katherine A High · Children'S Hosp Of Philadelphia · P01 · FY2009 · HL

ROLES AND REGULATION OF P53

$1,915,338
Columbia Univ New York Morningside · P01 · FY2000 · CA

Biology and Transplantation of the Hematopoietic Stem Cell

$1,914,901
John E Wagner · University Of Minnesota · P01 · FY2016 · CA

Biology and Transplantation of the Hematopoietic Stem Cell

$1,914,865
John E Wagner · University Of Minnesota · P01 · FY2017 · CA

Biology and Transplantation of the Hematopoietic Stem Cell

$1,914,832
John E Wagner · University Of Minnesota · P01 · FY2018 · CA

Roles of Chromatin-modifying Factors in Epigenetic Control of the Genome

$1,914,602
Shivinder S Grewal · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

RNAi and Epigenetic Control of Higher-Order Chromatin Assembly

$1,914,602
Shivinder S Grewal · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Growth Factor Imaging and Photoimmunotherapy

$1,914,491
Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Development of Novel Therapies for NIDDM

$1,914,412
Christopher B Newgard · Duke University · P01 · FY2010 · DK

Molecular Mechanisms of Arterigenesis

$1,913,890
Michael Simons · Yale University · P01 · FY2019 · HL

Molecular Diagnosis, Prognosis, and Therapeutic Targets in Lymphoma

$1,913,660
Lisa Rimsza · Mayo Clinic Arizona · P01 · FY2022 · CA

Developing a kit-based research use only (RUO) translocation assay for deployment as a lab developed test (LDT) toward changing outcomes for patients with driver-negative tumors

$1,913,603
Siddarth Selvaraj · Arima Genomics, Inc. · R44 · FY2024 · CA

Alcohol Pharmacokinetics and Pharmacodynamics in Humans

$1,913,347
Vijay Arjun Ramchandani · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2025 · AA

Structure and Function of DNA Repair Enzymes

$1,913,214
Susan S Wallace · University Of Vermont & St Agric College · P01 · FY2014 · CA

Neurosurgical Oncology Unit

$1,913,214
Desmond Brown · National Institute Of Neurological Disorders And Stroke · ZIA · FY2024 · NS

Systems-level Analysis of Heart and Muscle Development in Drosophila

$1,913,076
Alan Michelson · National Heart, Lung, And Blood Institute · ZIA · FY2010 · HL

p53, Aging, and Cancer

$1,912,927
Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Investigating the role of transposable element dysregulation as a driver of neurotoxicity in tauopathy

$1,912,681
Bess Frost · University Of Texas Hlth Science Center · RF1 · FY2019 · NS

Chromatin Structure and Gene Expression

$1,912,649
Gordon L Hager · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

SPORE IN OVARIAN CANCER

$1,912,606
University Of Alabama At Birmingham · P50 · FY2001 · CA

Mayo Alzheimer's Disease Research Center

$1,912,298
Ronald C Petersen · Mayo Clinic Rochester · P50 · FY2016 · AG

Epidemiology of putative genuine genetic variant: The Women's Health Intiative

$1,912,247
Charles L Kooperberg · Fred Hutchinson Cancer Research Center · U01 · FY2011 · HG

Molecular Mechanisms of Arterigenesis

$1,912,161
Michael Simons · Yale University · P01 · FY2022 · HL

COVID-19: Assay Development, HTS and Drug Repurposing to identify potential therapeutics against SARS-CoV-2

$1,912,140
Matthew Hall · National Center For Advancing Translational Sciences · ZIA · FY2021 · TR